Condition
Neuroendocrine Gastroenteropancreatic Tumour clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Neuroendocrine Gastroenteropancreatic Tumour clinical trials that are recruiting, at sites in 2 countries (most in India (1), France (1)). By phase: Phase 3 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
PRRT alone versus PRRT plus chemotherapy for gastroenteropancreatic neuroendocrine tumors
This test sees if adding capecitabine–temozolomide chemotherapy to Lutetium‑177 DOTATATE PRRT helps adults with advanced gastroenteropancreatic neuroendocrine tumors live longer without the cancer getting worse.
-
Intra-arterial liver infusion of radiolabeled somatostatin drugs for gastroenteropancreatic neuroendocrine tumors with dominant liver metastases
This will test whether giving radiolabeled somatostatin medication directly into the liver works better than the usual IV route for people with gastroenteropancreatic neuroendocrine tumors whose disease mainly affects the liver after four Lutathera treatments.
Related topics
Quick answers
How many Neuroendocrine Gastroenteropancreatic Tumour clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in India (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.